COVID-19 in teriflunomide-treated patients with multiple sclerosis

The outbreak of a severe acute respiratory syndrome caused by a novel coronavirus (COVID-19), has raised health concerns for patients with multiple sclerosis (MS) who are commonly on long-term immunotherapies. Managing MS during the pandemic remains challenging with little published experience and n...

Descripción completa

Detalles Bibliográficos
Autores principales: Maghzi, Amir Hadi, Houtchens, Maria K., Preziosa, Paolo, Ionete, Carolina, Beretich, Biljana D., Stankiewicz, James M., Tauhid, Shahamat, Cabot, Ann, Berriosmorales, Idanis, Schwartz, Tamara H. W., Sloane, Jacob A., Freedman, Mark S., Filippi, Massimo, Weiner, Howard L., Bakshi, Rohit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268971/
https://www.ncbi.nlm.nih.gov/pubmed/32494856
http://dx.doi.org/10.1007/s00415-020-09944-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268971/
https://www.ncbi.nlm.nih.gov/pubmed/32494856
http://dx.doi.org/10.1007/s00415-020-09944-8

Ejemplares similares